T 0108/21 (Treatment of multiple sclerosis/NOVARTIS) of 08.02.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T010821.20220208
- Date of decision
- 8 February 2022
- Case number
- T 0108/21
- Petition for review of
- -
- Application number
- 15177166.4
- IPC class
- A61P 37/06A61K 31/397A61K 31/137
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- S1P RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS
- Applicant name
- Novartis AG
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Main request - sufficiency of disclosure (yes)
Main request - novelty (yes)
Main request - inventive step (yes) - Catchword
- -
- Cited cases
- T 0609/02
- Citing cases
- T 1125/22
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division with the order to grant a patent on the basis of the single claim of the main request filed on 18 November 2019 underlying the impugned decision and resubmitted with the statement of grounds of appeal, and a description to be adapted thereto.